Meetings of the Minds2005

U.S.-Japan meeting cooperative cataract research group (CCRG)

  • DAY: to be released
  • Place：Kona, Hawaii, USA
  • ①Low proteolytic activity by the calpain/calpastatin system causes resistance to calcium-induced proteolysis in primate lenses
    ②Characterization of Up84 calpain, a p94 splice variant in human lens
    ③C-terminal truncation of aB-crystallin in calcium-induced cataract from cultured primate lenses
  • ①Ryan D. Walkup, Emi Nakajima, Mitsuyoshi Azuma, and Thomas R. Shearer
    ②Masakatsu Higashine, Hong Ma, Chiho Fukiage, Mitsuyoshi Azuma, and Thomas R. Shearer
    ③Emi Nakajima, Michael A. Riviere, Larry L. David, Mitsuyoshi Azuma and Thomas R. Shearer

13th NA ISSX Meeting/20th JSSX Meeting

  • DAY: to be released
  • Place：Wailea Marriott Resort, Wailea, Maui, Hawaii
  • Structure modification of SJA6017 for improving oral availability
  • Y.Shirasaki, M.yamaguchi, H.Miyashita, J.Inoue, M.Nakamura

30th FEBS Congress - 9th IUBMB Conference

  • DAY: to be released
  • Place：Budapest, Hungary
  • Contribution of calpain to cellular damage in human retinal pigment epithelium cultured with zinc chelator
  • Y. Tamada1, T. Nakajima1, T. R. Shearer2 M. Azuma1,2.
    1Senju Pharmaceutical Co., Ltd., Kobe, Japan; 2Oregon Health & Science University, Portland, OR.

The Association for Research in Vision and Ophthalmology (ARVO) 2005 Annual Meeting

  • DAY: to be released
  • Place：Fort Lauderdale, Florida, U.S.A.
  • ①Self-Induction of Lacritin in Human Corneal and Conjunctival Cells
    ②Involvement of Calpain in Retinal Ganglion Cell Damage: Proposed Mechanism for Glaucoma in Rat and Human
    ③Calpain Inhibition Attenuates Loss of Retinal Function in Experimental Optic Neuritis
    ④In vitro Degradation of Human Aquaporin 0 by M-Calpain
    ⑤Cloning and Characterization of Lacritin in Monkey
    ⑥Involvement of Calpain in Retinal Degeneration Induced By N-Methyl-N-Nitrosourea in the Rats
    ⑦Intraocular Concentration of Triamcinolone Acetonide After Sub-Tenon Injection
  • ①M.Azuma1,2, T.Nakajima1, M.Higashine1, T.R. Shearer2, C.Fukiage1.
    　1 Research Laboratory of Ocular Science, Senju Pharmaceutical Co Ltd, Kobe, Japan; 2 Department of Integrative Biosciences, Oregon Health & Science University, Portland, OR.
    ②Y.Tamada1, E.Nakajima1,2, T.Oka1, T.R. Sheare2r, M.Azuma1,2.
    　1 Senju Pharmaceutical Co., Ltd., Kobe, Japan; 2 Oregon Health & Science University, Portland, OR.
    ③M.K. Guyton1A, B.Rohrer2, M.Azuma3, J.Inoue3, S.K. Ray1B, N.L. Banik1B.
    　A Microbiology & Immunology, B Neuroscience, 1 Medical Univ of South Carolina, Charleston, SC; 2 Ophthamology, Medical University of South Carolina, Charleston, SC; 3 Senju Pharmaceutical Corporation Limited, Kobe, Japan.
    ④H.Ma1, L.L. David1, M.A. Reviere1, M.Azuma1,2, T.R. Shearer1.
    　1 Integrative Biosciences, Oregon Health Science Univ SD, Portland, OR; 2 Senju Pharmaceutical Co. Ltd, Kobe, Japan.
    ⑤T.Nakajima1, C.Fukiage1, Y.Tamada1, M.Higashine1, T.R. Shearer2,M.Azuma1,2.
    　1 Research Laboratory of Ocular Science, Senju Pharmaceutical Co., Ltd., Kobe, Japan; 2 Department of Integrative Biosciences, Oregon Health & Science University, Portland, OR.
    ⑥T.Oka1, T.Nakajima1, T.R. Shearer2, M.Azuma1,2.
    　1 Research Laboratories, Senju Pharmaceutical Co., Ltd., Kobe, Japan; 2 Department of Integrative Biosciences, Oregon Health & Science University, Portland, OR.
    ⑦M. Higashiyama, A. Ohtori.
    　Research Laboratories, Senju Pharmaceutical Co., Ltd., Kobe, Japan

Experimental Biology 2005 (EB 2005)

  • DAY: to be released
  • Place：San Diego, CA, U.S.A.: April 2-6,2005
  • Contribution of calpain 2-induced proteolysis to experimental cataract in cultured primate lenses
  • E. Nakajima1,2, ,M.Azuma1,2,　T.R. Shearer2.
    1Research Laboratory of Ocular Science, Senju Pharmaceutical Co Ltd, Kobe, Japan; 2Oregon Health & Science University, Portland, OR.

new | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999